Lumb Vanshika, Das Manoj K, Mittra Pooja, Ahmed Anwar, Kumar Manoj, Kaur Punit, Dash Aditya P, Singh Shiv S, Sharma Yagya D
Department of Biotechnology, All India Institute of Medical Sciences, New Delhi, India.
J Infect Dis. 2009 Apr 1;199(7):1064-73. doi: 10.1086/597206.
Enormous amounts of drugs were used to contain the outbreak of infectious diseases in areas of India affected by the tsunami in December 2004. The impact of this drug use on the Plasmodium falciparum population needs to be investigated.
The nucleotide sequence of the pfcrt, pfdhps, and pfdhfr genes was determined for 229 clinical P. falciparum isolates collected from patients on Car Nicobar Island at 6 different time points between May 2004 and May 2008.
Over time, there was an increase in the proportion of the P. falciparum population that had mutations in the pfcrt, pfdhps, and pfdhfr genes associated with higher levels of chloroquine, sulfadoxine, and pyrimethamine resistance, respectively. However, the parasites collected during October 2005 had mutations associated with a lower level of pyrimethamine resistance and a higher level of sulfadoxine resistance (a rare combination), as well as a novel K540N mutation in P. falciparum dihydropteroate synthetase (PfDHPS). The emergence of this parasite population coincided with the widespread use of an additional antifolate drug, trimethoprim-sulfamethoxazole, to treat other infections during January- March 2005. Molecular modeling revealed that the sulfadoxine binding affinity of the new PfDHPS triple mutant A436G437N540A581A613 was similar to that of A436G437E540A581A613 (bold type indicates mutated amino acids).
The use of 2 antifolate drugs in combination should be avoided to prevent the selection of parasites with newer mutations and altered drug susceptibilities
2004年12月,印度受海啸影响地区使用了大量药物来控制传染病的爆发。这种药物使用对恶性疟原虫群体的影响需要进行调查。
测定了2004年5月至2008年5月期间从卡尼科巴岛患者中收集的229株临床恶性疟原虫分离株的pfcrt、pfdhps和pfdhfr基因的核苷酸序列,共6个不同时间点。
随着时间的推移,恶性疟原虫群体中分别与氯喹、磺胺多辛和乙胺嘧啶耐药性水平较高相关的pfcrt、pfdhps和pfdhfr基因突变比例有所增加。然而,2005年10月收集的寄生虫具有与较低乙胺嘧啶耐药性水平和较高磺胺多辛耐药性水平相关的突变(一种罕见组合),以及恶性疟原虫二氢蝶酸合酶(PfDHPS)中的一种新的K540N突变。这种寄生虫群体的出现与2005年1月至3月期间广泛使用另一种抗叶酸药物甲氧苄啶-磺胺甲恶唑治疗其他感染相吻合。分子模拟显示,新的PfDHPS三联突变体A436G437N540A581A613的磺胺多辛结合亲和力与A436G437E540A581A613相似(粗体表示突变氨基酸)。
应避免联合使用两种抗叶酸药物,以防止选择具有新突变和改变药物敏感性的寄生虫。